LabCorp Extends Tender Offer for Orchid Cellmark Again | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today extended its cash tender offer for Orchid Cellmark to Aug. 12, 5 p.m. EDT.

The extension is the fourth as the US Federal Trade Commission seeks additional information about the deal. The $85.4 million deal was originally announced in April and was expected to close in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: transcriptomic analysis of the Venus flytrap, SMASH approach for CNV analysis, and more.

A Caltech professor wins the Millennium Technology Prize that lauds technological advances that improve human life.

San Diego's biotech scene has a dearth of executives who are women, Stat News reports.

Some 90 percent of respondents to a Nature survey say there is a research reproducibility crisis.